Quest Magazine

First Drug for Duchenne Muscular Dystrophy Gets 'Conditional Approval' in Europe

DMD: Ataluren Receives Conditional Approval in Europe

PTC Therapeutics Receives Conditional Approval in the European Union for Translarna™ for the treatment of Nonsense Mutation Duchenne Muscular Dystrophy

ISIS-SMNRx to Be Tested in Phase 3 Trial in Infants With SMA

Safeway Inc. and The Safeway Foundation Fundraising Campaign to Support Programs for People with Disabilities

Jiffy Lube® Supports Fight Against Muscle Disease With Third Annual MUSCLE UP® Campaign

Fire Fighters and MDA Celebrate “60 Years Strong”

DMD: ReveraGen Drug Will Move to Human Testing

International Consortium Provides $2M Funding for Phase 1 Clinical Trial of ReveraGen DMD Drug

DMD: Eteplirsen Data Still Encouraging at 144 Weeks

Pages